• Laurent DECORY

Among 2019 top 10 Biotech IPOs, 5 reached more than 1 $Bn valuation

Updated: Mar 24, 2020

Among 2019 top 10 Biotech IPOs Genmab's $505 million came #1, while BridgeBio Pharma, Gossamer Bio, Alector and BioNTech also joined the billion-plus valuation club.


Half of top IPOs were cancer-focussed, followed by genetic diseases.


2020 forecast remains uncertain, for now.


Continue reading


#biotech #ipo



9 views0 comments